Bright Minds Biosciences Inc. (DRUG) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bright Minds Biosciences ...

    NASDAQ: DRUG · Real-Time Price · USD
    42.17
    0.00 (0.00%)
    At close: Sep 10, 2025, 3:59 PM
    41.50
    -1.59%
    After-hours: Sep 10, 2025, 07:45 PM EDT

    Bright Minds Biosciences Income Statement

    Financials in CAD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -2.62M -7.2M -14.73M -8.62M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -2.8M -7.37M -14.96M -8.65M
    Net Income
    		 -2.8M -7.37M -14.96M -8.65M
    Selling & General & Admin
    		 1.44M 2.2M 2.55M 2.31M
    Research & Development
    		 1.18M 5M 12.18M 6.31M
    Other Expenses
    		 n/a n/a -0.00 0.00
    Operating Expenses
    		 2.62M 7.2M 14.73M 8.62M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 41.6K 119.42K 551.86K 852.15K
    Cost & Expenses
    		 2.62M 7.2M 14.73M 8.62M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 4.31M 3.72M 2.47M 1.79M
    Shares Outstanding (Diluted)
    		 4.31M 3.72M 2.47M 1.79M
    EPS (Basic)
    		 -0.65 -1.98 -6.15 -4.74
    EPS (Diluted)
    		 -0.65 -1.98 -6.15 -4.74
    EBITDA
    		 n/a -7.28M -14.96M n/a
    EBIT
    		 -2.62M -7.35M -14.73M -8.65M
    Depreciation & Amortization
    		 2.62M 72.45K 6.04K 8.62M

    Add to Watchlist